1. Home
  2. ALAR vs PASG Comparison

ALAR vs PASG Comparison

Compare ALAR & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$1.78

Market Cap

13.1M

Sector

Technology

ML Signal

HOLD

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

HOLD

Current Price

$4.64

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
PASG
Founded
2013
2017
Country
Israel
United States
Employees
N/A
27
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
14.8M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ALAR
PASG
Price
$1.78
$4.64
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$14.00
$14.00
AVG Volume (30 Days)
★ 165.0K
25.2K
Earning Date
05-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.51
N/A
Revenue Next Year
$33.43
N/A
P/E Ratio
$44.31
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$3.29
52 Week High
$16.56
$20.00

Technical Indicators

Market Signals
Indicator
ALAR
PASG
Relative Strength Index (RSI) 44.22 46.26
Support Level $1.62 $4.27
Resistance Level $2.10 $4.95
Average True Range (ATR) 0.20 0.26
MACD 0.01 -0.03
Stochastic Oscillator 20.52 20.13

Price Performance

Historical Comparison
ALAR
PASG

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: